Arrowstreet Capital, Limited Partnership Selecta Biosciences Inc Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.89 - $4.43 $537,074 - $823,266
-185,839 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$3.36 - $4.62 $624,419 - $858,576
185,839 New
185,839 $773,000
Q4 2020

Feb 12, 2021
SELL
$1.64 - $3.42 $113,984 - $237,700
-69,503 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$2.18 - $2.84 $207,311 - $270,075
-95,097 Reduced 57.77%
69,503 $172,000
Q2 2020

Aug 12, 2020
BUY
$1.83 - $4.06 $301,218 - $668,275
164,600 New
164,600 $467,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email